Moderna says its RNA vaccine was nearly 84% effective in preventing symptoms in adults 60 and older

Moderna Inc. announced on Tuesday that a late-stage trial found that its experimental messenger RNA vaccine for respiratory syncytial virus was 83.7% effective in preventing at least two symptoms in … Read More

Powered by WP Robot